<p><strong>SAN JOSE </strong>&#8212; Mendel, a clinical artificial intelligence and natural language processing platform, has raised $40 million in Series B funding round led by Oak HC/FT. The round includes participation from existing investor DCM, who led Mendel&#8217;s Series A funding round in June 2021. </p>
<p>This funding comes amidst surging customer demand for Mendel&#8217;s AI infrastructure. The fresh capital will enable the company to expand its team of AI and engineering teams and scale the commercial organization. It will also help accelerate the release of Mendel&#8217;s new, breakthrough product, Resolve, which consolidates clinical information to create a coherent longitudinal view of the patient journey. Traditionally, it takes nearly five years to manually abstract 2 million patient lives. Mendel&#8217;s Resolve abstracts the same number in less than 24 hours.</p>
<p>&#8220;The capital we have raised is a testament to the strong market fit and demand,&#8221; said Karim Galil, Co-Founder and CEO of Mendel. &#8220;Our vision it to weave Mendel into the fabric of every healthcare data platform. It&#8217;s exciting to partner with Oak HC/FT as we enable the healthcare ecosystem to provide better care for every patient.&#8221;</p>
<p>The healthcare industry faces immense challenges in parsing unstructured medical data that is highly valuable, but also extremely difficult and expensive to access. Mendel&#8217;s solution unlocks 80% of the world&#8217;s clinical data by leveraging contextual understanding to transform unstructured electronic medical record (EMR) data and clinical literature into comprehensive and compliant analytics-ready data. It abstracts data 27,000 times faster than the primarily manual methods most frequently used in clinical settings, and its output is reviewed and validated by a team of clinical experts to guarantee research-grade output.</p>
<p>&#8220;We believe Mendel can become a mission-critical infrastructure platform for the healthcare industry,&#8221; said Billy Deitch, Partner at Oak HC/FT. &#8220;Mendel&#8217;s technology sets a new standard in accuracy and scalability for processing unstructured medical data and we are confident that the company will continue to lead the industry with cutting edge solutions [and delivering for their customers].&#8221; </p>

SAN JOSE -- Lumilens, a connectivity platform for AI infrastructure, has emerged from stealth, having…
SAN FRANCISCO – Expedition Therapeutics, a clinical-stage biotechnology company developing novel oral small molecule therapies…
SAN FRANCISCO -- Convex, a backend platform designed for reliability at scale, has landed a $57 million…
SAN FRANCISCO -- Aurelius Systems has closed a $40 million Series A funding round. The…
SANTA CLARA – Marvell Technology, a provider of data infrastructure semiconductor solutions, announced new innovations across its…
PALO ALTO -- Simile -- an AI-based simulation company -- has raised $200 million at…